XML 28 R12.htm IDEA: XBRL DOCUMENT
v3.21.2

Accrued Expenses | 6 Months Ended
--- | ---
Jun. 30, 2021
Payables and Accruals [Abstract] |
Accrued Expenses | Accrued Expenses Accrued expenses consisted of the following (in thousands):
| June 30, 2021 |  | December 31, 2020
Legal costs | $ | 7,161 |  |  | $ | 14,822 |
Settlement costs | 4,495 |  |  | 9,975 |
Commissions to sales agents | 1,823 |  |  | 2,141 |
Estimated returns | 777 |  |  | 688 |
Accrued clinical trials | 686 |  |  | 651 |
Accrued GPO fees | 520 |  |  | 554 |
Accrued rebates | 372 |  |  | 886 |
Other | 1,239 |  |  | 743 |
Total | $ | 17,073 |  |  | $ | 30,460 |

X
- Definition The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a),20,24) -URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration